From: Machine learning in lymphocyte and immune biomarker analysis for childhood thyroid diseases in China
 |  | Median (IQR) | P | |
---|---|---|---|---|
Normal Range | Control (N = 283) | Cases (N = 139) | ||
CD3-CD16 + 56+ | 6 ~ 27% | 9.63 (6.69 ~ 13.19) | 8.08 (5.42 ~ 11.69) | 0.006 |
CD3-CD19+ | 7 ~ 22% | 16.88 (13.55 ~ 21.67) | 17.06 (13.40 ~ 22.13) | 0.526 |
CD3 + CD4+ | 31 ~ 60% | 36.02 (31.88 ~ 40.61) | 39.37 (33.83 ~ 43.74) | < 0.001 |
CD3 + CD8+ | 13 ~ 38% | 27.34 (23.21 ~ 31.17) | 24.64 (21.10 ~ 27.88) | 0.001 |
CD4+/CD8+ | 0.9 ~ 3.6 | 1.32 (1.07 ~ 1.68) | 1.57 (1.28 ~ 1.96) | < 0.001 |
CD4 + CD8+ | 0 ~ 3% | 1.05 (0.68 ~ 1.51) | 0.78 (0.48 ~ 1.23) | 0.001 |